Buy Myovant Sciences Stock | MYOV Stock Price & Latest News | Public
MYOV

Myovant Sciences

$0.00 (0.00%)Today

    About MYOV

    Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of women's health and endocrine diseases. The company's product includes relugolix, which is an oral, once-daily and small mole...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.25
    -0.5
    -0.75
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.69

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,42B
    Volume17,34k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$23.04
    1 Year Low$4.14
    Open$15.80
    High$15.90
    Low$15.07

    Buy any stock with any amount of money.

    Download the App
    Download the app